Phage protein-targeted cancer nanomedicines

FEBS Letters

Volumn 588, Issue 2, 2014, Pages 341-349

  Petrenko, V A ^a   Jayanna, P K ^a  

^a AUBURN UNIVERSITY   (United States)

Author keywords

Landscape phage; Major coat protein; Nanomedicine; Phage display; Targeted drug delivery

Indexed keywords

ANTINEOPLASTIC AGENT; COAT PROTEIN; GOLD NANOPARTICLE; LIPOSOME; MACROGOL; SMALL INTERFERING RNA;

BINDING AFFINITY; CANCER CELL; CYTOTOXICITY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG MIXTURE; DRUG TARGETING; GENE TARGETING; HYDROPHILICITY; NANOMEDICINE; PEPTIDE LIBRARY; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; PROTEIN TARGETING; REVIEW; RNA INTERFERENCE; TARGET CELL;

1,2-DIOLEOYL-3-TRIMETHYLAMMONIUM-PROPANE; 1,2-DIPALMITOYL-SN-GLYCERO-3-[PHOSPHO-RAC-(1-GLYCEROL)]; 1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE-N-[AMINO(POLYETHYLENE GLYCOL)2000]; CELL-PENETRATING PEPTIDES; CHOL; CHOLESTEROL; CPP; DIPHENYLHEXATRIENE; DOTAP; DPH; DPPG; EPC; FET; FLUORESCENCE ENERGY TRANSFER; LANDSCAPE PHAGE; LIGAND-MEDIATED TARGETING; LMT; MAJOR COAT PROTEIN; NANOMEDICINE; PEG; PEG2K-PE; PHAGE DISPLAY; PHOSPHATIDYLCHOLINE (EGG); POLYETHYLENE GLYCOL; SIRNA; SMALL INTERFERING RNA; TARGETED DRUG DELIVERY; TM; TRANS-MEMBRANE;

ANIMALS; BACTERIOPHAGES; DRUG DELIVERY SYSTEMS; HUMANS; MOLECULAR TARGETED THERAPY; NANOMEDICINE; NEOPLASMS; VIRAL PROTEINS;

EID: 84892369453     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2013.11.011     Document Type: Review

References (108)

1. D.S. Alberts, and D.J. Garcia Safety aspects of pegylated liposomal doxorubicin in patients with cancer Drugs 54 Suppl. 4 1997 30 35
2. A. Gabizon, R. Catane, B. Uziely, B. Kaufman, T. Safra, R. Cohen, F. Martin, A. Huang, and Y. Barenholz Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes Cancer Res. 54 1994 987 992
3. B. Uziely, S. Jeffers, R. Isacson, K. Kutsch, D. Wei-Tsao, Z. Yehoshua, E. Libson, F.M. Muggia, and A. Gabizon Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies J. Clin. Oncol. 13 1995 1777 1785
4. M. Everts Targeted therapies directed to tumor-associated antigens Drugs Future 30 2005 1067 1076
5. C.O. Noble, D.B. Kirpotin, M.E. Hayes, C. Mamot, K. Hong, J.W. Park, C.C. Benz, J.D. Marks, and D.C. Drummond Development of ligand-targeted liposomes for cancer therapy Expert Opin. Ther. Targets 8 2004 335 353
6. V.P. Torchilin Drug targeting Eur. J. Pharm. Sci. 11 2000 S81 S91
7. J.K. Vasir, and V. Labhasetwar Targeted drug delivery in cancer therapy Technol. Cancer Res. Treat. 4 2005 363 374
8. I.K. Kwon, S.C. Lee, B. Han, and K. Park Analysis on the current status of targeted drug delivery to tumors J. Control. Release 164 2012 108 114
9. J. Shi, Z. Xiao, N. Kamaly, and O.C. Farokhzad Self-assembled targeted nanoparticles: evolution of technologies and bench to bedside translation Acc. Chem. Res. 44 2011 1123 1134
10. R.K. Jain Physiological barriers to delivery of monoclonal antibodies and other macromolecules in tumors Cancer Res. 50 1990 814 819
11. K. Fujimori, D.G. Covell, J.E. Fletcher, and J.N. Weinstein Modeling analysis of the global and microscopic distribution of immunoglobulin G, F(ab′)2, and Fab in tumors Cancer Res. 49 1989 5656 5663
12. G.P. Adams, R. Schier, A.M. McCall, H.H. Simmons, E.M. Horak, R.K. Alpaugh, J.D. Marks, and L.M. Weiner High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules Cancer Res. 61 2001 4750 4755
13. R.M. Reilly, J. Sandhu, T.M. Alvarez-Diez, S. Gallinger, J. Kirsh, and H. Stern Problems of delivery of monoclonal antibodies. Pharmaceutical and pharmacokinetic solutions Clin. Pharmacokinet. 28 1995 126 142
14. E. Ruoslahti Peptides as targeting elements and tissue penetration devices for nanoparticles Adv. Mater. 24 2012 3747 3756
15. R.C. Ladner, A.K. Sato, J. Gorzelany, and M. de Souza Phage display-derived peptides as therapeutic alternatives to antibodies Drug Discovery Today 9 2004 525 529
16. O.H. Aina, R. Liu, J.L. Sutcliffe, J. Marik, C.X. Pan, and K.S. Lam From combinatorial chemistry to cancer-targeting peptides Mol. Pharm. 4 2007 631 651
17. R. Craig, and S. Li Function and molecular mechanism of tumor-targeted peptides for delivering therapeutic genes and chemical drugs Mini-Rev. Med. Chem. 6 2006 757 764
18. L. Krumpe, and T. Mori The use of phage-displayed peptide libraries to develop tumor-targeting drugs Int. J. Pept. Res. Ther. 12 2006 79 91
19. S.V. Garde, A.J. Forté, M. Ge, E.A. Lepekhin, C.J. Panchal, S.A. Rabbani, and J.J. Wu Binding and internalization of NGR-peptide-targeted liposomal doxorubicin (TVT-DOX) in CD13-expressing cells and its antitumor effects Anticancer Drugs 18 2007 1189
20. E. Koivunen, W. Arap, H. Valtanen, A. Rainisalo, O.P. Medina, P. Heikkila, C. Kantor, C.G. Gahmberg, T. Salo, Y.T. Konttinen, T. Sorsa, E. Ruoslahti, and R. Pasqualini Tumor targeting with a selective gelatinase inhibitor Nat. Biotechnol. 17 1999 768 774
21. O.P. Medina, T. Soderlund, L.J. Laakkonen, E.K.J. Tuominen, E. Koivunen, and P.K.J. Kinnunen Binding of novel peptide inhibitors of type IV collagenases to phospholipid membranes and use in liposome targeting to tumor cells in vitro Cancer Res. 61 2001 3978 3985
22. F. Pastorino, C. Brignole, D. Di Paolo, B. Nico, A. Pezzolo, D. Marimpietri, G. Pagnan, F. Piccardi, M. Cilli, R. Longhi, D. Ribatti, A. Corti, T.M. Allen, and M. Ponzoni Targeting liposomal chemotherapy via both tumor cell-specific and tumor vasculature-specific ligands potentiates therapeutic efficacy Cancer Res. 66 2006 10073 10082
23. H. Slimani, E. Guenin, D. Briane, R. Coudert, N. Charnaux, A. Starzec, R. Vassy, M. Lecouvey, Y.G. Perret, and A. Cao Lipopeptide-based liposomes for DNA delivery into cells expressing neuropilin-1 J. Drug Target. 14 2006 694 706
24. T.-Y. Lee, C.-T. Lin, S.-Y. Kuo, D.-K. Chang, and H.-C. Wu Peptide-mediated targeting to tumor blood vessels of lung cancer for drug delivery Cancer Res. 67 2007 10958 10965
25. T.-Y. Lee, H.-C. Wu, Y.-L. Tseng, and C.-T. Lin A novel peptide specifically binding to nasopharyngeal carcinoma for targeted drug delivery Cancer Res. 64 2004 8002 8008
26. J.F. Stefanick, J.D. Ashley, T. Kiziltepe, and B. Bilgicer A systematic analysis of peptide linker length and liposomal polyethylene glycol coating on cellular uptake of peptide-targeted liposomes ACS Nano 7 2013 2935 2947
27. L. Nobs, F. Buchegger, R. Gurny, and E. Allemann Current methods for attaching targeting ligands to liposomes and nanoparticles J. Pharm. Sci. 93 2004 1980 1992
28. L. Nobs, F. Buchegger, R. Gurny, and E. Allemann Coupling methods to obtain ligand-targeted liposomes and nanoparticles Drugs Pharm. Sci. 158 2006 123 148
29. D.F. Nellis, D.L. Ekstrom, D.B. Kirpotin, J. Zhu, R. Andersson, T.L. Broadt, T.F. Ouellette, S.C. Perkins, J.M. Roach, D.C. Drummond, K. Hong, J.D. Marks, J.W. Park, and S.L. Giardina Preclinical manufacture of an anti-HER2 scFv-PEG-DSPE, liposome-inserting conjugate. 1. Gram-scale production and purification Biotechnol Prog. 21 2005 205 220
30. V. Petrenko Evolution of phage display: from bioactive peptides to bioselective nanomaterials Expert Opin. Drug Deliv. 5 2008 825 836
31. D. Bedi, J.W. Gillespie, V.A. Petrenko Jr, A. Ebner, M. Leitner, P. Hinterdorfer, and V.A. Petrenko Targeted delivery of siRNA into breast cancer cells via phage fusion proteins Mol. Pharm. 10 2013 551 559
32. D. Bedi, T. Musacchio, O.A. Fagbohun, J.W. Gillespie, P. Deinnocentes, R.C. Bird, L. Bookbinder, V.P. Torchilin, and V.A. Petrenko Delivery of siRNA into breast cancer cells via phage fusion protein-targeted liposomes Nanomed. Nanotechnol. Biol. Med. 7 2011 315 323
33. J.R. Brigati, T.I. Samoylova, P.K. Jayanna, and V.A. Petrenko Phage display for generating peptide reagents Curr. Protoc. Protein Sci. 2008 Chapter 18, Unit 18 9
34. P. Jayanna, D. Bedi, P. Deinnocentes, R. Bird, and V. Petrenko Landscape phage ligands for PC3 prostate carcinoma cells Protein Eng. Des. Sel. 23 2010 423 430
35. P.K. Jayanna, D. Bedi, J.W. Gillespie, P. DeInnocentes, T. Wang, V.P. Torchilin, R.C. Bird, and V.A. Petrenko Landscape phage fusion protein-mediated targeting of nanomedicines enhances their prostate tumor cell association and cytotoxic efficiency Nanomed. Nanotechnol. Biol. Med. 6 2010 538 546
36. P.K. Jayanna, V.P. Torchilin, and V.A. Petrenko Liposomes targeted by fusion phage proteins Nanomed. Nanotechnol. Biol. Med. 5 2009 83 89
37. Petrenko, V.A. (2012) Drug Delivery Nanocarriers Targeted by Landscape Phage. United States Patents US 8,137,693 B2. March 20, 2012. Divisional US 8,252,324 B2. Aug 28, 2012.
38. T. Wang, G.G. D'Souza, D. Bedi, O.A. Fagbohun, L.P. Potturi, B. Papahadjopoulos-Sternberg, V.A. Petrenko, and V.P. Torchilin Enhanced binding and killing of target tumor cells by drug-loaded liposomes modified with tumor-specific phage fusion coat protein Nanomedicine 5 2010 563 574
39. T. Wang, N. Kulkarni, D. Bedi, G.G. D'Souza, B. Papahadjopoulos- Sternberg, V.A. Petrenko, and V.P. Torchilin In vitro optimization of liposomal nanocarriers prepared from breast tumor cell specific phage fusion protein J. Drug Target. 19 2011 597 605
40. T. Wang, N. Kulkarni, G.G. D'Souza, V.A. Petrenko, and V.P. Torchilin On the mechanism of targeting of phage fusion protein-modified nanocarriers: only the binding peptide sequence matters Mol. Pharm. 8 2011 1720 1728
41. T. Wang, V. Petrenko, and V.P. Torchilin Optimization of landscape phage fusion protein-modified polymeric Peg-Pe micelles for improved breast cancer cell targeting J. Nanomed. Nanotechnol. 2012
42. T. Wang, V.A. Petrenko, and V.P. Torchilin Paclitaxel-loaded polymeric micelles modified with MCF-7 cell-specific phage protein: enhanced binding to target cancer cells and increased cytotoxicity Mol. Pharm. 7 2010 1007 1014
43. T. Wang, S. Yang, V.A. Petrenko, and V.P. Torchilin Cytoplasmic delivery of liposomes into MCF-7 breast cancer cells mediated by cell-specific phage fusion coat protein Mol. Pharm. 7 2010 1149 1158
44. G.P. Smith, and V.A. Petrenko Phage display Chem. Rev. 97 1997 391 410
45. H.M. Geysen, R.H. Meloen, and S.J. Barteling Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid Proc. Natl. Acad. Sci. USA 81 1984 3998 4002
46. R.A. Houghten General-method for the rapid solid-phase synthesis of large numbers of peptides - specificity of antigen-antibody interaction at the level of individual amino-acids Proc. Natl. Acad. Sci. USA 82 1985 5131 5135
47. H.M. Geysen, F. Schoenen, D. Wagner, and R. Wagner Combinatorial compound libraries for drug discovery: an ongoing challenge Nat. Rev. Drug Discovery 2 2003 222 230
48. A.A. Ilyichev, O.O. Minenkova, S.I. Tatkov, N.N. Karpyshev, A.M. Eroshkin, V.A. Petrenko, and L.S. Sandakhchiev Construction of M13 viable bacteriophage with the insert of foreign peptides into the major coat protein Dokl. Biochem. (Proc. Acad. Sci. USSR)-Engl. Trans. 307 1989 196 198
49. G.P. Smith Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface Science 228 1985 1315 1317
50. V.A. Petrenko, and G.P. Smith Vectors and modes of display S.S. Sidhu, Phage Display in Biotechnology and Drug Discovery 2005 CRC Press, Taylor & Francis Group Bo Raton, FL, USA 714
51. M.A. Arap Phage display technology: applications and innovations Genet. Mol. Biol. 28 2005 1 9
52. A. Merzlyak, and S.-W. Lee Phage as templates for hybrid materials and mediators for nanomaterial synthesis Curr. Opin. Chem. Biol. 10 2006 246 252
53. M. Paschke Phage display systems and their applications Appl. Microbiol. Biotechnol. 70 2006 2 11
54. S.S. Sidhu Phage display in pharmaceutical biotechnology Curr. Opin. Biotechnol. 11 2000 610 616
55. V.A. Petrenko, G.P. Smith, X. Gong, and T. Quinn A library of organic landscapes on filamentous phage Protein Eng. 9 1996 797 801
56. G.A. Kuzmicheva, P.K. Jayanna, I.B. Sorokulova, and V.A. Petrenko Diversity and censoring of landscape phage libraries Protein Eng. Des. Sel. 22 2009 9 18
57. O.A. Fagbohun, D. Bedi, N.I. Grabchenko, P.A. Deinnocentes, R.C. Bird, and V.A. Petrenko Landscape phages and their fusion proteins targeted to breast cancer cells Protein Eng. Des. Sel. 25 2012 271 283
58. G. Abbineni, S. Modali, B. Safiejko-Mroczka, V.A. Petrenko, and C. Mao Evolutionary selection of new breast cancer cell-targeting peptides and phages with the cell-targeting peptides fully displayed on the major coat and their effects on actin dynamics during cell internalization Mol. Pharm. 7 2010 1629 1642
59. V.I. Romanov, D.B. Durand, and V.A. Petrenko Phage display selection of peptides that affect prostate carcinoma cells attachment and invasion Prostate 47 2001 239 251
60. T.I. Samoylova, V.A. Petrenko, N.E. Morrison, L.P. Globa, H.J. Baker, and N.R. Cox Phage probes for malignant glial cells Mol. Cancer Ther. 2 2003 1129 1137
61. K.A. Kelly, and D.A. Jones Isolation of a colon tumor specific binding peptide using phage display selection Neoplasia 5 2003 437 444
62. K.A. Kelly, S.R. Setlur, R. Ross, R. Anbazhagan, P. Waterman, M.A. Rubin, and R. Weissleder Detection of early prostate cancer using a hepsin-targeted imaging agent Cancer Res. 68 2008 2286 2291
63. K.A. Kelly, P. Waterman, and R. Weissleder In vivo imaging of molecularly targeted phage Neoplasia 8 2006 1011 1018
64. J.R. Newton, K.A. Kelly, U. Mahmood, R. Weissleder, and S.L. Deutscher In vivo selection of phage for the optical imaging of PC-3 human prostate carcinoma in mice Neoplasia 8 2006 772 780
65. J.R. Newton-Northup, S.D. Figueroa, T.P. Quinn, and S.L. Deutscher Bifunctional phage-based pretargeted imaging of human prostate carcinoma Nucl. Med. Biol. 36 2009 789 800
66. S. Carnazza, C. Foti, G. Gioffrè, F. Felici, and S. Guglielmino Specific and selective probes for Pseudomonas aeruginosa from phage-displayed random peptide libraries Biosens. Bioelectron. 23 2008 1137 1144
67. S. Carnazza, G. Gioffre, F. Felici, and S. Guglielmino Recombinant phage probes for Listeria monocytogenes J. Phys.: Condens. Matter 19 2007 395011
68. I.B. Sorokulova, E.V. Olsen, I.H. Chen, B. Fiebor, J.M. Barbaree, V.J. Vodyanoy, B.A. Chin, and V.A. Petrenko Landscape phage probes for Salmonella typhimurium J. Microbiol. Methods 63 2005 55 72
69. J. Brigati, D.D. Williams, I.B. Sorokulova, V. Nanduri, I.H. Chen, C.L. Turnbough Jr., and V.A. Petrenko Diagnostic probes for Bacillus anthracis spores selected from a landscape phage library Clin. Chem. 50 2004 1899 1906
70. J.D. Mount, T.I. Samoylova, N.E. Morrison, N.R. Cox, H.J. Baker, and V.A. Petrenko Cell targeted phagemid rescued by preselected landscape phage Gene 341 2004 59 65
71. T.I. Samoylova, N.R. Cox, N.E. Morrison, L.P. Globa, V. Romanov, H.J. Baker, and V.A. Petrenko Phage matrix for isolation of glioma cell membrane proteins Biotechniques 37 2004 254 260
72. Suiqiong Li, Ramji S. Lakshmanan, Valery A. Petrenko, and B.A. Chin Phage-based pathogen biosensors V.A. Petrenko, G.P. Smith, Phage Nanobiotechnology 2011 Royal Society of Chemistry Cambridge, UK 273
73. V.A. Petrenko, and J.R. Brigati Phage as biospecific probes J.M. Van Emon, Immunoassay and Other Bioanalytical Techniques 2007 CRC Press, Taylor & Francis Group Boca Raton, FL
74. C.E. Flynn, S.-W. Lee, B.R. Peelle, and A.M. Belcher Viruses as vehicles for growth, organization and assembly of materials Acta Mater. 51 2003 5867 5880
75. C. Mao, D.J. Solis, B.D. Reiss, S.T. Kottmann, R.Y. Sweeney, A. Hayhurst, G. Georgiou, B. Iverson, and A.M. Belcher Virus-based toolkit for the directed synthesis of magnetic and semiconducting nanowires Science 303 2004 213 217
76. E.V. Olsen, I.B. Sorokulova, V.A. Petrenko, I.H. Chen, J.M. Barbaree, and V.J. Vodyanoy Affinity-selected filamentous bacteriophage as a probe for acoustic wave biodetectors of Salmonella typhimurium Biosens. Bioelectron. 21 2006 1434 1442
77. B. Cao, and C. Mao Filamentous phage-templated synthesis and assembly of inorganic nanomaterials V.A. Petrenko, G.P. Smith, Phage Nanobiotechnology 2011 Royal Society of Chemistry Cambridge, UK 273
78. R. Webster Filamentous phage biology Carlos F. Barbas III Dennis R. Barton, Jamie K. Scott, G.J. Silverman, Phage Display: A Laboratory Manual 2001 Cold Spring Harbor Laboratory Press NY
79. R.B. Spruijt, C. Wolfs, and M.A. Hemminga Aggregation-related conformational change of the membrane-associated coat protein of bacteriophage M13 Biochemistry 28 1989 9158 9165
80. D.A. Marvin, R.D. Hale, C. Nave, and M. Helmer-Citterich Molecular models and structural comparisons of native and mutant class I filamentous bacteriophages Ff (fd, f1, M13), If1 and IKe J. Mol. Biol. 235 1994 260 286
81. W.L. Vos, P.V. Nazarov, R.B. Koehorst, R.B. Spruijt, and M.A. Hemminga From 'I' to 'L' and back again: the odyssey of membrane-bound M13 protein Trends Biochem. Sci. 34 2009 249 255
82. S. Lee, M.F. Mesleh, and S.J. Opella Structure and dynamics of a membrane protein in micelles from three solution NMR experiments J. Biomol. NMR 26 2003 327 334
83. A.C. Zeri, M.F. Mesleh, A.A. Nevzorov, and S.J. Opella Structure of the coat protein in fd filamentous bacteriophage particles determined by solid-state NMR spectroscopy Proc. Natl. Acad. Sci. USA 100 2003 6458 6463
84. M. Soekarjo, M. Eisenhawer, A. Kuhn, and H. Vogel Thermodynamics of the membrane insertion process of the M13 procoat protein, a lipid bilayer traversing protein containing a leader sequence Biochemistry 35 1996 1232 1241
85. D. Kiefer, and A. Kuhn Hydrophobic forces drive spontaneous membrane insertion of the bacteriophage Pf3 coat protein without topological control EMBO J. 18 1999 6299 6306
86. Y. Su, T. Doherty, A.J. Waring, P. Ruchala, and M. Hong Roles of arginine and lysine residues in the translocation of a cell-penetrating peptide from (13)C, (31)P, and (19)F solid-state NMR Biochemistry 48 2009 4587 4595
87. E. Thiaudiere, M. Soekarjo, E. Kuchinka, A. Kuhn, and H. Vogel Structural characterization of membrane insertion of M13 procoat, M13 coat, and Pf3 coat proteins Biochemistry 32 1993 12186 12196
88. A.N.J.A. Ridder, W. van de Hoef, J. Stam, A. Kuhn, B. de Kruijff, and J.A. Killian Importance of hydrophobic matching for spontaneous insertion of a single-spanning membrane protein Biochemistry 41 2002 4946 4952
89. Matsuo, T., Matsuo, T., Yamamoto, T., Niiyama, K., Yamazaki, N.A.Y.N., Ishida, T.A.I.T., Kiwada, H.A.K.H., Shinohara, Y.A.S.Y., Kataoka, M.A.K.M. (2007). Design, preparation and directional insertion of peptides into lipid bilayer membrane and their application for the preparation of liposome of which surface could be coated by externally added antibody. Paper Presented at the Micro-NanoMechatronics and Human Science, 2007.
90. V.I. Romanov Phage display selection and evaluation of cancer drug targets Curr. Cancer Drug Targets 3 2003 119 129
91. T.M. Allen, and C. Hansen Pharmacokinetics of stealth versus conventional liposomes: effect of dose Biochim. Biophys. Acta 1068 1991 133 141
92. L. Arleth, B. Ashok, H. Onyuksel, P. Thiyagarajan, J. Jacob, and R.P. Hjelm Detailed structure of hairy mixed micelles formed by phosphatidylcholine and PEGylated phospholipids in aqueous media Langmuir 21 2005 3279 3290
93. C.W. Pouton, and L.W. Seymour Key issues in non-viral gene delivery Adv. Drug Deliv. Rev. 34 1998 3 19
94. S.-S. Kim, H. Garg, A. Joshi, and N. Manjunath Strategies for targeted non-viral delivery of siRNAs in vivo Trends Mol. Med. 15 2009 491 500
95. Y.L. Chiu, A. Ali, C. Chu, H. Cao, and T.M. Rana Visualizing a correlation between siRNA localization, cellular uptake, and RNAi in living cells Chem. Biol. 11 2004 1165 1175
96. J. Elmén, H. Thonberg, K. Ljungberg, M. Frieden, M. Westergaard, Y. Xu, B. Wahren, Z. Liang, H. ∅rum, and T. Koch Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality Nucleic Acids Res. 33 2005 439
97. J. Soutschek, A. Akinc, B. Bramlage, K. Charisse, R. Constien, M. Donoghue, S. Elbashir, A. Geick, P. Hadwiger, and J. Harborth Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs Nature 432 2004 173 178
98. X. Zheng, C. Vladau, X. Zhang, M. Suzuki, T.E. Ichim, Z.-X. Zhang, M. Li, E. Carrier, B. Garcia, and A.M. Jevnikar A novel in vivo siRNA delivery system specifically targeting dendritic cells and silencing CD40 genes for immunomodulation Blood 113 2009 2646 2654
99. Y.-L. Tseng, J.-J. Liu, and R.-L. Hong Translocation of liposomes into cancer cells by cell-penetrating peptides penetratin and tat: a kinetic and efficacy study Mol. Pharmacol. 62 2002 864 872
100. K.F. Pirollo, and E.H. Chang Targeted delivery of small interfering RNA: approaching effective cancer therapies Cancer Res. 68 2008 1247
101. W. Wang, N. Tang, C.L. Zhang, X.J. Liu, H. Hu, Z.X. Zhang, and W. Liang Cell penetrating peptides enhance intracellular translocation and function of siRNA encapsulated in pegylated liposomes Yao Xue Xue Bao 41 2006 142
102. S.D. Li, S. Chono, and L. Huang Efficient oncogene silencing and metastasis inhibition via systemic delivery of siRNA Mol. Ther. 16 2008 942 946
103. N. Nishikawa, M. Toyota, H. Suzuki, T. Honma, T. Fujikane, T. Ohmura, T. Nishidate, M. Ohe-Toyota, R. Maruyama, and T. Sonoda Gene amplification and overexpression of PRDM14 in breast cancers Cancer Res. 67 2007 9649 9657
104. D.J. Gary, N. Puri, and Y.-Y. Won Polymer-based siRNA delivery: perspectives on the fundamental and phenomenological distinctions from polymer-based DNA delivery J. Controlled Release 121 2007 64 73
105. V.A. Petrenko Landscape phage as a molecular recognition interface for detection devices Microelectron. J. 39 2008 202 207
106. V.A. Petrenko, G.P. Smith, M.M. Mazooji, and T. Quinn Alpha-helically constrained phage display library Protein Eng. 15 2002 943 950
107. G.A. Kuzmicheva, P.K. Jayanna, A.M. Eroshkin, M.A. Grishina, E.S. Pereyaslavskaya, V.A. Potemkin, and V.A. Petrenko Mutations in fd phage major coat protein modulate affinity of the displayed peptide Protein Eng. Des. Sel. 22 2009 631 639
108. D. Stopar, R.B. Spruijt, C.J. Wolfs, and M.A. Hemminga Protein-lipid interactions of bacteriophage M13 major coat protein Biochim. Biophys. Acta 1611 2003 5 15